Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM ET

Register Free →

Therapeutic Development for Drug-Resistant Infectious Diseases

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract focuses on the development of therapeutic candidates designed to treat drug-resistant infectious diseases in support of prime contractors for the National Institutes of Health and the National Institute of Allergy and Infectious Diseases. The scope of work encompasses the identification and synthesis of candidates, efficacy testing against resistant strains, and comprehensive safety profiling and toxicity testing. To successfully execute these tasks, the provider must possess specialized chemical synthesis equipment, antimicrobial susceptibility testing capabilities, and the necessary biosafety certifications. The primary deliverables for this engagement include validated therapeutic candidates, detailed safety and efficacy data, and strategic maturation plans. This opportunity is categorized under NAICS code 325412 and is associated with the Department of Health and Human Services. Interested parties should note the response deadline of December 8, 2026.

General Info

Subcontract for developing drug-resistant infectious disease therapeutics for NIH, due December 8, 2026.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

MD

Set-Aside

NONE

Documents

This scope was carved out of HHS-NIH-NIAID-BAA2026-1.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Niaid
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Develops therapeutic candidates to treat drug-resistant infectious diseases for prime contractors on NIH/NIAID projects. Performs identification and synthesis of candidates, efficacy testing against drug-resistant strains, and safety profiling and toxicity testing. Requires specialized chemical synthesis equipment, antimicrobial susceptibility testing (AST) capabilities, and biosafety certifications. Delivers validated therapeutic candidates, safety/efficacy data, and maturation plans.

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
PERMETHRIN CREAM RINSE
Solicitation # SPE2DP-27-T-0080
Solicitation SPE2DP-27-T-0080, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is for the procurement of Permethrin Cream Rinse (NSN 6505-01-256-4972). The required product must contain a 1% w/v Permethrin active ingredient and be supplied in 2 fl oz plastic squeeze bottles that include a comb. The total quantity requested across four line items is 11 units. The product has a total shelf life of 24 months, with a strict requirement that at least 21 months of shelf life remain upon receipt by the first government activity. Delivery is required within 20 days after order to various destination points, including USNS Loyal, USNS Lewis and Clark, and USNS Leroy Grumman. As an FDA-regulated drug or device, the product must adhere to Medical Marking Standard No. 1 and MIL-STD-129. Packaging must be commercial, utilizing suitable sealed unit containers, with hazardous materials specifically complying with Federal Standard No. 313-E and TQ requirement IP025. Suppliers are required to submit Safety Data Sheets (SDS) and Hazardous Communication Standard labels prior to award. Contract administration requires the use of the Wide Area WorkFlow (WAWF) system for invoicing and payment. The solicitation incorporates various FAR and DFARS clauses, including those regarding the Buy American Act, safeguarding covered defense information, and prohibitions on covered defense telecommunications equipment. Quotations are due by October 14, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

4 days ago

DEADLINE

in 1 day
View Details
NAICS: 325412
New
Federal
6505--Lab Supplies - Radiopharm Philadelphia VA Medical Center
Solicitation # 36C24427Q0018
The Department of Veterans Affairs, Network Contracting Office 4, is soliciting quotations for an indefinite-quantity contract to provide essential radiopharmaceuticals and calibration sources for the Corporal Michael J. Crescenz VA Medical Center Nuclear Medicine Department. The contract covers a five-year period of performance from November 1, 2026, to October 31, 2031, consisting of a base year and four option years. The selected vendor must be licensed and accredited by the Nuclear Regulatory Commission and comply with all regulations from the DOT, NHPP, FDA, and OSHA. Deliveries are to be made to a secure location at the medical center, with routine orders due by 8:00 AM the following workday and same-day deliveries required within two hours of order placement during normal business hours. The scope of work includes the supply of various radiopharmaceutical kits and calibration sources, such as Co57 and Tc99m variants. Contractors must ensure all radioactive materials are clearly labeled with proper class and exposure levels, and unit doses must include preparation and expiration details. Additionally, the vendor must provide bar-labeled inserts compatible with the PineStar Nuclear Medicine Information Management System or provide a compatible system, including data migration and training, at no additional cost. Award will be based on a comparative evaluation of price and past performance, with a preference for HUBZone Small Business Concerns. Quotations must be submitted electronically to the Contracting Officer in two parts: a price quotation and past performance information from the last three years. Invoicing is to be handled monthly and submitted electronically via the Austin Payment Center.
244-NETWORK Contract Office 4 (36C244)

POSTED

5 days ago

DEADLINE

in 3 days
View Details

More opportunities from Department Of Health And Human Services → National Institutes Of Health Niaid

Same awarding agency

NAICS: 541715
New
Federal
2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases
Solicitation # HHS-NIH-NIAID-BAA2026-1
The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting proposals under Broad Agency Announcement HHS-NIH-NIAID-BAA2026-1 to advance the research and development of medical interventions for infectious diseases. This initiative focuses on three primary research areas: the development of needle-free vaccine candidates through early-phase clinical trials; the creation of safe and effective therapeutic candidates for serious infectious diseases, including those resistant to current antimicrobial therapy; and the innovation of in vitro diagnostic technology platforms capable of rapid, automated detection of a broad panel of priority viral pathogens. The program emphasizes alignment with NIH priorities regarding biosafety, biosecurity, and the use of non-animal testing methods. Proposals must be submitted electronically via the NIAID eCPS website by December 8, 2026, at 3:00 PM Eastern Time. Technical proposals are limited to 75 pages and will be evaluated by a peer review group based on technical merit, with the technical plan and personnel qualifications being of paramount consideration. Awards are not based on a common Statement of Work; instead, offerors must propose their own technical plans, milestones, and cost structures using a base and option period format. The resulting contracts will require an accounting system compliant with generally accepted accounting principles and will involve rigorous government inspection and acceptance based on the successful completion of critical milestones.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

4 days ago

DEADLINE

in about 2 months
View Details
NAICS: 622110
New
Federal
NOI RML Regional Referral Hospital Care and Isolation Unit Services
Solicitation # NOI-PCA-NIAID-00838
The National Institutes of Health intends to award a sole-source, firm-fixed-price contract to Providence St. Patrick Hospital in Missoula, Montana, to provide critical care and isolation services for personnel at the Rocky Mountain Laboratories (RML) in Hamilton, Montana. This requirement is mandated by a federal lawsuit settlement agreement and federal select agent regulations, including 42 CFR Part 73, 9 CFR Part 121, and 7 CFR Part 331. The contractor must maintain a Care and Isolation Unit within a 75-mile radius of RML, featuring a negative pressure room for evaluations and the capacity to provide full intensive care clinical services for at least 72 hours. Key operational requirements include 24/7/365 availability of an infectious disease specialist and the ability to activate the isolation unit within six hours of a request. The contract is structured with a base year running from September 29, 2026, to September 28, 2027, followed by four option years, with a total estimated value of $1,094,085.52 and a base year cost of $253,991.00. Providence St. Patrick Hospital is identified as the only responsible source capable of meeting these specialized needs, specifically as a NSPS/NETEC Level 3 Assessment Center that complies with JCAHO and CLIA standards. The procurement is conducted under the authority of 41 U.S.C. 3304(a)(1) and FAR 6.302.1(b)(1)(i), as no other medical facility within the required geographic radius can satisfy the agency's mission-critical safety and regulatory requirements.
General Medical and Surgical Hospitals

POSTED

7 days ago

DEADLINE

in 3 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS